Resistance to arsenic therapy in acute promyelocytic leukemia

N Engl J Med. 2014 May 8;370(19):1864-6. doi: 10.1056/NEJMc1316382.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arsenic Trioxide
  • Arsenicals / therapeutic use*
  • Drug Resistance, Neoplasm / genetics*
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Leukemia, Promyelocytic, Acute / genetics*
  • Mutation
  • Neoplasm Proteins / genetics*
  • Oxides / therapeutic use*
  • Receptors, Retinoic Acid / genetics*
  • Retinoic Acid Receptor alpha

Substances

  • Arsenicals
  • Neoplasm Proteins
  • Oxides
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • Arsenic Trioxide